Management of anaphylaxis due to COVID‐19 vaccines in the elderly
Male
COVID-19 vaccines
older (adults
GUIDELINES
0302 clinical medicine
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Medicine and Health Sciences
info:eu-repo/classification/ddc/618
Immunology and Allergy
[SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases
[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology
MESH: Aged
RISK
Vaccines
[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases
people)
EPINEPHRINE
General medicine, internal medicine and other clinical medicine
[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
3. Good health
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases
COVID -19 vaccines
[SDV.MP.PAR] Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology
older (adults/people)
Risk
COVID-19 Vaccines
Epinephrine
MESH: Covid-19
MESH: Epinephrine
Anaphylaxis / etiology
Immunology
adrenaline; anaphylaxis; COVID-19 vaccines; older (adults/people); Aged; COVID-19 Vaccines; Epinephrine; Humans; Male; SARS-CoV-2; Anaphylaxis; COVID-19
Guidelines
Adrenaline
03 medical and health sciences
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
Anaphylaxis/etiology
anaphylaxis
Humans
MESH: SARS-CoV-2
[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology
Anaphylaxis
Older - Adults/people
Aged
MESH: Humans
adrenaline
SARS-CoV-2
adrenaline, anaphylaxis, COVID-19 vaccines, older (adults/people)
COVID-19
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
Anaphylaxis / prevention & control
300
MESH: Male
MESH: Anaphylaxis
Older
[SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
MESH: Covid-19 vaccines
Older (adults/people)
DOI:
10.1111/all.14838
Publication Date:
2021-04-03T02:20:55Z
AUTHORS (149)
ABSTRACT
Older adults, especially men and/or those with diabetes, hypertension, obesity, are prone to severe COVID-19. In some countries, older particularly residing in nursing homes, have been prioritized receive COVID-19 vaccines due high risk of death. very rare instances, the can induce anaphylaxis, and management anaphylaxis people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis its Impact on Asthma, European Academy Allergy Clinical Immunology, Geriatric Medicine Society) Working Group has proposed recommendations for adults receiving vaccines. Anaphylaxis is extremely (from 1 per 100,000 5 million injections). Symptoms similar younger but they tend more patients. Adrenaline mainstay treatment readily available. A flowchart manage
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....